{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:26:00Z","timestamp":1787225160544,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1994,4,1]],"date-time":"1994-04-01T00:00:00Z","timestamp":765158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1994,4]]},"DOI":"10.1007\/bf01834364","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T13:32:31Z","timestamp":1119965551000},"page":"183-188","source":"Crossref","is-referenced-by-count":22,"title":["Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity"],"prefix":"10.1007","volume":"68","author":[{"given":"D.","family":"Przepiorka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ippoliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Diener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01834364_CR1","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD et al. (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6:1562\u20131568","journal-title":"J Clin Oncol"},{"key":"BF01834364_CR2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.1989.7.9.1288","volume":"7","author":"SI Bearman","year":"1989","unstructured":"Bearman SI, Appelbaum FR, Back A et al. (1989) Regimenrelated toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 7:1288\u20131294","journal-title":"J Clin Oncol"},{"key":"BF01834364_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00000421-199006000-00009","volume":"13","author":"R Brodsky","year":"1990","unstructured":"Brodsky R, Topolsky D, Crilley P et al. (1990) Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan\/cyclophosphamide preparative regimen. Am J Clin Oncol 13:221\u2013225","journal-title":"Am J Clin Oncol"},{"issue":"Suppl 1","key":"BF01834364_CR4","first-page":"72a","volume":"80","author":"CD Buckner","year":"1992","unstructured":"Buckner CD, Clift RA, Appelbaum FR et al. (1992) A randomized study comparing two transplant regimens for CML in chronic phase (CP). Blood 80 [Suppl 1]:72a","journal-title":"Blood"},{"key":"BF01834364_CR5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V78.3.838.838","volume":"78","author":"EA Copelan","year":"1991","unstructured":"Copelan EA, Biggs JC, Thompson JM et al. (1991) Treatment of acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 78:838\u2013843","journal-title":"Blood"},{"key":"BF01834364_CR6","volume-title":"Analysis of binary data","author":"DR Cox","year":"1989","unstructured":"Cox DR, Snell EJ (1989) Analysis of binary data. Chapman and Hall, New York"},{"key":"BF01834364_CR7","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood.V82.8.2324.bloodjournal8282324","volume":"82","author":"MA Dimopoulos","year":"1993","unstructured":"Dimopoulos MA, Alexanian R, Przepiorka D et al. (1993) Thiotepa, busulfan and cyclophosphamide: a new preparative regimen for autologous marrow or peripheral blood stem cell transplantation in high-risk multiple myeloma. Blood 82:2324\u20132328","journal-title":"Blood"},{"key":"BF01834364_CR8","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","volume":"79","author":"JH Essell","year":"1992","unstructured":"Essell JH, Thompson JM, Harman GS et al. (1992) Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan\/cyclophosphamide. Blood 79:2784\u20132788","journal-title":"Blood"},{"key":"BF01834364_CR9","first-page":"41","volume":"9","author":"RB Geller","year":"1992","unstructured":"Geller RB, Myers S, Devine S et al. (1992) Phase-I study of busulfan, cyclophosphamide and timed sequential escalating doses of cytarabine followed by bone marrow transplantation. Bone Marrow Transplant 9:41\u201347","journal-title":"Bone Marrow Transplant"},{"key":"BF01834364_CR10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorner WE et al. (1987) Veno-oc-clusive disease of the liver following bone marrow transplantation. Transplantation 44:778\u2013783","journal-title":"Transplantation"},{"key":"BF01834364_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF01834364_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. (1984) Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatol 4:116\u2013122","journal-title":"Hepatol"},{"issue":"Suppl 1","key":"BF01834364_CR13","first-page":"140a","volume":"80","author":"CB Miller","year":"1990","unstructured":"Miller CB, Hayashi RJ, Vogelsang GB et al. (1990) Aseptic shock syndrome after bone marrow transplantation (BMT). Blood 80 [Suppl 1]:140a","journal-title":"Blood"},{"issue":"Suppl 1","key":"BF01834364_CR14","first-page":"291a","volume":"80","author":"C Miller","year":"1992","unstructured":"Miller C, Wagner JE, Vogelsang GB et al. (1992) A randomized trial of busulfan-cyclophosphamide (BU-CY) versus cyclophosphamide-total body irradiation (CY-TBI) as preparative regimen for patients with chronic myelogenous leukemia (CML). Blood 80 [Suppl 1]:291a","journal-title":"Blood"},{"key":"BF01834364_CR15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1200\/JCO.1991.9.7.1224","volume":"9","author":"TJ Nevill","year":"1991","unstructured":"Nevill TJ, Barnett MJ, Klingemann H-G et al. (1991) Regimen related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncol 9:1224\u20131232","journal-title":"J Clin Oncol"},{"key":"BF01834364_CR16","first-page":"6402","volume":"47","author":"WP Peters","year":"1987","unstructured":"Peters WP, Henner WD, Grochow LB et al. (1987) Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. Cancer Res 47:6402\u20136406","journal-title":"Cancer Res"},{"key":"BF01834364_CR17","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1991.9.10.1880","volume":"9","author":"GL Phillips","year":"1991","unstructured":"Phillips GL, Shepherd JD, Barnett MJ et al. (1991) Busulfan, cyclophosphamide and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy. J Clin Oncol 9:1880\u20131888","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"BF01834364_CR18","first-page":"337a","volume":"80","author":"D Przepiorka","year":"1992","unstructured":"Przepiorka D, Ippoliti C, Ownby K et al. (1992) A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation. Blood 80 [Suppl 1]:337a","journal-title":"Blood"},{"issue":"Suppl 1","key":"BF01834364_CR19","first-page":"144a","volume":"82","author":"D Przepiorka","year":"1993","unstructured":"Przepiorka D, Nath R, Ippoliti C et al. (1993) A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide with autologous marrow transplantation for lymphoma. Blood 82 [Suppl 1]: 144a","journal-title":"Blood"},{"key":"BF01834364_CR20","first-page":"49","volume":"9","author":"V Ratanatharathorn","year":"1992","unstructured":"Ratanatharathorn V, Karanes C, Lum LG et al. (1992) Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). Bone Marrow Transplant 9:49\u201355","journal-title":"Bone Marrow Transplant"},{"key":"BF01834364_CR21","first-page":"139","volume":"11","author":"DE Reece","year":"1993","unstructured":"Reece DE, Barnett MJ, Connors JM et al. (1993) Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide. Bone Marrow Transplant 11:139\u2013146","journal-title":"Bone Marrow Transplant"},{"key":"BF01834364_CR22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9343(89)80606-0","volume":"87","author":"RA Robbins","year":"1989","unstructured":"Robbins RA, Linder J, Stahl MG et al. (1989) Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 87:511\u2013518","journal-title":"Am J Med"},{"key":"BF01834364_CR23","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","volume":"309","author":"GW Santos","year":"1983","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R et al. (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309:1347\u20131353","journal-title":"N Engl J Med"},{"key":"BF01834364_CR24","first-page":"197","volume":"10","author":"HM Shulman","year":"1992","unstructured":"Shulman HM, Hinterberger W (1992) Hepatic veno-occlusive disease \u2014 liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 10:197\u2013214","journal-title":"Bone Marrow Transplant"},{"key":"BF01834364_CR25","first-page":"2774","volume":"19","author":"R Storb","year":"1987","unstructured":"Storb R (1987) Critical issues in bone marrow transplantation. Transplant Proc 19:2774\u20132781","journal-title":"Transplant Proc"},{"key":"BF01834364_CR26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","volume":"49","author":"ED Thomas","year":"1977","unstructured":"Thomas ED, Buckner CD, Banaji M et al. (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511\u2013533","journal-title":"Blood"},{"key":"BF01834364_CR27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","volume":"70","author":"PJ Tutschka","year":"1987","unstructured":"Tutschka PJ, Copelan EA, Klein JP (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70:1382\u20131388","journal-title":"Blood"},{"key":"BF01834364_CR28","first-page":"211","volume":"8","author":"RHC Jagt Van der","year":"1991","unstructured":"Van der Jagt RHC, Appelbaum FR, Petersen FB et al. (1991) Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplant 8:211\u2013215","journal-title":"Bone Marrow Transplant"},{"key":"BF01834364_CR29","first-page":"489","volume":"8","author":"WP Vaughan","year":"1991","unstructured":"Vaughan WP, Dennsison JD, Reed EC et al. (1991) Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy. Bone Marrow Transplant 8:489\u2013495","journal-title":"Bone Marrow Transplant"},{"key":"BF01834364_CR30","first-page":"2","volume":"17","author":"SN Wolff","year":"1990","unstructured":"Wolff SN, Herzig RH, Fay JW et al. (1990) High-dose N,N\u2032,N\u2033-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase-I studies. Semin Oncol 17:2\u20136","journal-title":"Semin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01834364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01834364\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01834364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:59:19Z","timestamp":1586307559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01834364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,4]]}},"alternative-id":["BF01834364"],"URL":"https:\/\/doi.org\/10.1007\/bf01834364","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,4]]}}}